An analyst from Master Capital Trust said that Reliance is witnessing a strong bullish setup on the monthly chart as prices ...

Lupin shares continue to rise, trading at a new 52-week high of Rs 2,376 after a 15% return over two weeks. The Nifty Pharma ...

Nilesh Gupta, Managing Director of Lupin, emphasised that this acquisition aligns with the company’s commitment to expanding ...

The multinational pharmaceutical company had previously used distribution and promotion agreements with Eli Lilly to market the Huminsulin line of products. Indian pharma giant Lupin's shares ...

The drug is indicated for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of HIV-1 ...

Global pharma major Lupin Limited announced today the acquisition of Huminsulin® in India from Eli Lilly and Company to ...

Lupin strengthens its diabetes portfolio with the acquisition of Huminsulin products from Eli Lilly, including Insulin Human ...

Lupin Ltd. acquires Huminsulin range from Eli Lilly, strengthening its position in the Indian diabetes market.

Mumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to ...

Lupin Ltd has acquired the anti-diabetic medicine Huminsulin in India from Eli Lilly to expand its diabetes portfolio. This ...

The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and ...